TTX-333

N/A

Report date: 2025/03/28 16:04:31

Base Information

Drug NameTTX-333
Drug Alias NameDipeptideFibrosis prevention dipeptideEvitarTTX-333
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPost-surgical adhesions
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Saskatchewan
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPost-surgical adhesions

Other Information

ATC CodeN/A
Related LinksN/A